USPTO Deadlines
Next Deadline
In Grace Period
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20190813)
Due Date
August 13, 2025
Grace Period Ends
February 13, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 11, 2020 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Oct 11, 2019 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Sep 23, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 23, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 12, 2019 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Aug 13, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 28, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 8, 2019 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Apr 13, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 13, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 22, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 18, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 14, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, excluding products used in cell therapy or gene therapy or for treatment of blood diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005